Abstract
THE existence of decreased or absent thyroxine-binding globulin in the serums of certain asymptomatic subjects has been recognized since 1959, when the first case was described by Tanaka and Starr.1 In addition to a low serum protein-bound iodine concentration, serums from persons affected demonstrate a decrease or absence of thyroxine-binding globulin on paper electrophoresis, a normal binding capacity for thyroxine by thyroxine-binding prealbumin and an increase in the in vitro resin uptake of radioactive tri-iodothyronine. The disorder presents no clinical symptoms and causes no discernible ill-effects. The low concentration of protein-bound iodine is accompanied by an accelerated turnover of thyroxine, . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
